SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-22-113174
Filing Date
2022-04-21
Accepted
2022-04-21 17:10:38
Documents
13

Document Format Files

Seq Description Document Type Size
1 S-1/A d248113ds1a.htm S-1/A 1698222
2 EX-1.1 d248113dex11.htm EX-1.1 202240
3 EX-4.2 d248113dex42.htm EX-4.2 110525
4 EX-5.1 d248113dex51.htm EX-5.1 11587
5 EX-10.36 d248113dex1036.htm EX-10.36 99858
6 EX-23.1 d248113dex231.htm EX-23.1 1634
7 EX-FILING FEES d248113dexfilingfees.htm EX-FILING FEES 57785
8 GRAPHIC g248113g10a01.jpg GRAPHIC 129783
9 GRAPHIC g248113g10a02.jpg GRAPHIC 108430
10 GRAPHIC g248113g10a03.jpg GRAPHIC 44212
11 GRAPHIC g248113g10a04.jpg GRAPHIC 97655
12 GRAPHIC g248113g91s91.jpg GRAPHIC 148763
13 GRAPHIC g248113goodwin.jpg GRAPHIC 3318
  Complete submission text file 0001193125-22-113174.txt   2894957
Mailing Address 555 SKOKIE BOULEVARD, SUITE 340 NORTHBROOK IL 60062
Business Address 555 SKOKIE BOULEVARD, SUITE 340 NORTHBROOK IL 60062 (847) 562-4300
Clarus Therapeutics Holdings, Inc. (Filer) CIK: 0001817944 (see all company filings)

IRS No.: 851231852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-264231 | Film No.: 22842288
SIC: 2836 Biological Products, (No Diagnostic Substances)